Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,607.52 -562.06 (-0.88%) CMC Crypto 200
1,325.96 -70.57 (-5.05%)
Ligand Pharmaceuticals Incorporated (LGND)
| Previous close | 70.37 |
| Open | 70.59 |
| Bid | 70.79 x 100 |
| Ask | 71.55 x 100 |
| Day's range | 70.59 - 72.08 |
| 52-week range | 49.24 - 94.57 |
| Volume | |
| Avg. volume | 174,588 |
| Market cap | 1.261B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 23.51 |
| EPS (TTM) | 3.03 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jul 2010 |
| 1y target est | 116.80 |
Business WireLigand to Report First Quarter 2024 Financial Results on May 7, 2024
JUPITER, Fla., April 23, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, May 7, 2024, and will hold a conference call at 4:30 p.m. Eastern Time that same day to discuss financial results and provide a general business update.
ZacksWall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 45.6% in Ligand (LGND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ZacksAptevo (APVO) Stock Plummets 79% in a Week: Here's Why
Aptevo (APVO) plunges after it issues secondary shares, which are not only issued at a significant discount but also substantially dilute the existing shareholder base.
